Dentons Paris advised Laboratoires Expanscience on the acquisition of Medtech Sublimed, which develops medical devices for managing chronic pain. Historically specializing in the development of dermo-cosmetic products (Mustela), natural cosmetic active ingredients and rheumatology, Laboratoires Expanscience had a turnover of €324 million in 2022, 77% of which was generated internationally.
This acquisition enriches Laboratoires Expanscience’s portfolio of products for the treatment of osteoarthritis and allows it to diversify its expertise in research and development, as well as to develop its rheumatology business in the United States.
This agreement follows an ongoing collaboration between the two companies. Initiated in 2016 as part of Expanscience’s open innovation approach, it resulted in the development and marketing of VitaliTENS, as a non-drug analgesic alternative.
Laboratoires Expanscience is a long-standing client of Dentons’ Paris office. In 2018, Pascal Chadenet had already assisted the group in the acquisition of Babo Botanicals in the United States.
The Dentons Paris M&A team consisted of partner Pascal Chadenet and associate Imane Sayah.
Where the legal industry reads first.
Enjoyed this article? Get the biggest legal industry updates, deals, appointments, insights and expert interviews in your inbox, free.
No spam. Unsubscribe anytime.From Legal Desire
Is your firm the one being cited, or the one being skipped?
We ran the test. On several everyday legal questions, software companies are answering and law firms are not. We help firms fix that, and we build the technology behind the practice.
The advising firms, the named deal team, the value and the parties, with every other announced deal by the same firms and lawyers. Open the deal record
